“A Topical Combination of 0.1 % Rapamycin And 0.1 % Tacrolimus Ointment for the Treatment of Facial Angiofibromas in Tuberous Sclerosis Complex – A Pilot Study of 5 Cases”, Nepal J Dermatol Venereol & Leprol, vol. 24, no. 1, pp. 11–15, May 2026, doi: 10.3126/njdvl.v24i1.82147.